Literature DB >> 308930

Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses.

J Bennink, R B Effros, P C Doherty.   

Abstract

Mice were first primed with a type A or a type B influenza virus and then challenged intranasally at least 1 month later with another type A virus. Potent cytotoxic T cell populations were found in lung, and effector T cell function was also demonstrated in blood, spleen and mediastinal lymph nodes. Lymphocytes isolated from all of these anatomical sites were active against target cells infected with the same, or with serologically different, type A influenza viruses. Also, prior exposure to another type A virus resulted in more rapid development of effector function than was seen in mice that had first been infected with B/Lee. Cytotoxic T cell populations generated in mice with influenza thus tend overall to be type-specific, and there is substantial localization of these effector lymphocytes in the pneumonic lung.

Entities:  

Mesh:

Year:  1978        PMID: 308930      PMCID: PMC1457638     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Authors:  H J Zweerink; S A Courtneidge; J J Skehel; M J Crumpton; B A Askonas
Journal:  Nature       Date:  1977-05-26       Impact factor: 49.962

2.  Cytotoxic T cells specific for influenza virus-infected target cells.

Authors:  K L Yap; G L Ada
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

3.  Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.

Authors:  T J Braciale
Journal:  Cell Immunol       Date:  1977-10       Impact factor: 4.868

4.  Effects of low- and high-passage influenza virus infection in normal and nude mice.

Authors:  P R Wyde; R B Couch; B F Mackler; T R Cate; B M Levy
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

5.  Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens.

Authors:  F A Ennis; W J Martin; M W Verbonitz; G M Butchko
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

Authors:  J L SCHULMAN; E D KILBOURNE
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

7.  Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells.

Authors:  T J Braciale
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

8.  Hemagglutinin-specific cytotoxic T-cell response during influenza infection.

Authors:  F A Ennis; W J Martin; M W Verbonitz
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

9.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

Authors:  R B Effros; P C Doherty; W Gerhard; J Bennink
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

10.  Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses.

Authors:  W E Biddison; P C Doherty; R G Webster
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  17 in total

1.  The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines.

Authors:  Yuk-Fai Lau; Celia Santos; Fernando J Torres-Vélez; Kanta Subbarao
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

2.  Killer T cell responses to influenza A during a drift period: studies in mice.

Authors:  D Armerding; H Rossiter; E Liehl
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

3.  Respiratory mucosal immunization with reovirus serotype 1/L stimulates virus-specific humoral and cellular immune responses, including double-positive (CD4(+)/CD8(+)) T cells.

Authors:  S B Periwal; J J Cebra
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Identification of a unique population of tissue-memory CD4+ T cells in the airways after influenza infection that is dependent on the integrin VLA-1.

Authors:  Timothy J Chapman; David J Topham
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

5.  Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.

Authors:  M V Rayevskaya; F R Frankel
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.

Authors:  Grace L Chen; Yuk-Fai Lau; Elaine W Lamirande; Amber W McCall; Kanta Subbarao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-03       Impact factor: 11.205

Review 7.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

8.  Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system.

Authors:  J M Forger; R T Bronson; A S Huang; C S Reiss
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

Authors:  I M Belyakov; J D Ahlers; B Y Brandwein; P Earl; B L Kelsall; B Moss; W Strober; J A Berzofsky
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections.

Authors:  Mohammed Alsharifi; Yoichi Furuya; Timothy R Bowden; Mario Lobigs; Aulikki Koskinen; Matthias Regner; Lee Trinidad; David B Boyle; Arno Müllbacher
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.